Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
Graudins
A
A
Linden
C H
CH
Ferm
R P
RP
D005765:Gastrointestinal Agents / Q000627:therapeutic use; D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced* / Q000188:drug therapy; D007003:Hypoglycemia / Q000139:chemically induced* / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D015282:Octreotide / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000009:adverse effects*
D005765:Gastrointestinal Agents; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D015282:Octreotide; D005905:Glyburide